Results 31 to 40 of about 484,175 (264)

Simulated drug discovery process to conduct a synoptic assessment of pharmacy students. [PDF]

open access: yes, 2014
Objective. To implement and assess a task-based learning exercise that prompts pharmacy students to integrate their understanding of different disciplines. Design.
Moss, Gary P   +26 more
core   +1 more source

AMCP Partnership Forum: Navigating Innovations in Diabetes Care [PDF]

open access: yes, 2017
On July 19-20, 2016, Mark Tesell of Clinical Pharmacy Services participated in the Academy of Managed Care Pharmacy (AMCP) Partnership Forum, Navigating Innovations in Diabetes Care, in Arlington, VA. This invite-only event brought together AMCP members,
Tesell, Mark A.   +1 more
core   +1 more source

Managed Care Looks Forward: Top Five Trends for Pharmacy in 2019 [PDF]

open access: yes, 2019
In a commentary piece for Managed Health Care Connect, our Clinical Pharmacy Consultant Stephanie Tran, PharmD, overviews the top five pharmacy trends in managed care she's looking forward to in 2019.
Tran, Stephanie
core  

Pharmacogenetics and the Pharmacy Profession: A Sociological Exploration [PDF]

open access: yes, 2012
Pharmacy, particularly in the community setting, has been subject to significant changes over the last three decades. Running concurrently to these changes has been the development of the field of pharmacogenetics, or ‘personalised medicine’, which is ...
Jamie, Kimberly
core  

Conserved binding mode but diverse interfaces of MreC‐PBP2 interactions

open access: yesFEBS Letters, EarlyView.
The crystal structure of abMreC reveals a conserved two β‐barrel architecture and provides structural insights into its role within the bacterial elongasome. The abMreC–abPBP2 complex model identifies the molecular basis of MreC‐mediated PBP2 recognition, contributing to the regulation of peptidoglycan synthesis.
Hyunseok Jang   +4 more
wiley   +1 more source

Doctor of Pharmacy [PDF]

open access: yes, 1984
dissertationIn 1944, Professor L. Wait Rising proposed the concept of clinical pharmacy as an educational tool for undergraduate students in the School of Pharmacy at the University of Washington. The concept of pharmacists practicing in the patient care
Townsend, Paula Lynn   +1 more
core  

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Pharmacy practice in hyperdiverse, urban communities: perspectives of independent community pharmacists in East and South-East London [PDF]

open access: yes
This study considers pharmacy practice in hyperdiverse, urban communities through the eyes of independent community pharmacists, who are underrepresented figures in anthropological research.
Duckett, Kathryn
core   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy